How is the ITeos Therapeutics Inc today?

The ITeos Therapeutics Inc today is trading in the down by -1.56% at 8.22.

How has ITeos Therapeutics Inc performed historically?

The ITeos Therapeutics Inc is currently trading down -1.56% on an intraday basis in the past week the index rose 4.71%. The index has been up 9.89% in the past quarter and fell -54.56% in the past year. You can view this in the overview section.

What is ITeos Therapeutics Inc Annual Revenue?

ITeos Therapeutics Inc Annual Revenue rose 177.89%, in the last year to $35 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is ITeos Therapeutics Inc Annual Net Profit?

ITeos Therapeutics Inc Annual Net Profit fell 19.33% in the last year to $134.41 M. Its sector's average net profit growth for the last fiscal year was -11.16%.

What is ITeos Therapeutics Inc Price to Earning Ratio?

ITeos Therapeutics Inc Price to Earning Ratio is -2.41, which is negative.

What is ITeos Therapeutics Inc Stock Price?

ITeos Therapeutics Inc Stock Price fell 54.56% and underperformed its sector by 66.65% in the past year.

What is ITeos Therapeutics Inc Quarterly Net profit?

ITeos Therapeutics Inc Quarterly Net profit rose 9.43% YoY to $34.61 M. Its sector's average net profit growth YoY for the quarter was -200.49%.

What is ITeos Therapeutics Inc Debt to Equity Ratio?

ITeos Therapeutics Inc Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is ITeos Therapeutics Inc Return on Equity(ROE)?

ITeos Therapeutics Inc Return on Equity(ROE) for the last financial year was -23.06%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is ITeos Therapeutics Inc Mutual Fund Holding?

ITeos Therapeutics Inc Mutual Fund Holding decreased by 0.16% in the last quarter to 32.06.

What is ITeos Therapeutics Inc Institutional Holding?

ITeos Therapeutics Inc Institutional Holding decreased by 1.47% in the last quarter to 94.59.

ITeos Therapeutics Inc XNAS: ITOS

ITeos Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: ITeos Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: ITeos Therapeutics Inc
Rating: 1.4495555
Author: Trendlyne DVM scores

Momentum Trap

about

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include ...

8.22 -0.13 (-1.56%)

55.08% Fall from 52W High

2.0M XNAS Volume

XNAS 21 May, 2025 5:30 PM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

19.5 / 100

Technically Neutral

52.0 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 27%

5 analysts

ITeos Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ITeos Therapeutics Inc Live Share Price Today, Share Analysis and Chart

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include ...

55.08% Fall from 52W High

SWOT Analysis

ITeos Therapeutics Inc Live Price Chart

ITeos Therapeutics Inc FAQ

How is ITeos Therapeutics Inc today?

ITeos Therapeutics Inc today is trading in the red, and is down by -1.56% at 8.22.

How has ITeos Therapeutics Inc performed historically?

ITeos Therapeutics Inc is currently trading down -1.56% on an intraday basis. In the past week the stock rose 4.71%. stock has been up 9.89% in the past quarter and fell -54.56% in the past year. You can view this in the overview section.